(((9H-Fluoren-9-yl)methoxy)carbonyl)-L-valyl-L-alanine, 97%, 25g

3-Methylpyrazole-4-carboxaldehyde>98.0%(GC)200mg

2-[(2-bromoethyl)sulfanyl]-2-methylpropane, 95%, 250mg

PluriSIn 1>98.0%(HPLC)20mg

3-iso-Propoxybenzoic acid, 95.0%, 5g

Ethyl 3-methylpyrrolidine-3-carboxylate, 98%, 5g

Hexahidrato de ácido hexacloroplatínico (IV), 40 % Pt, 5 g, envase de vidrio

Methyl[(1-methyl-1H-imidazol-4-yl)methyl]amine, 97+%, 1g

4-(3-methoxyphenyl)-1H-pyrazol-5-amine hydrochloride, 95.0%, 1g

Methyl N-Boc-4-hydroxypiperidine-3-carboxylate, 95.0%, 1g

2-(1,3-dioxo-2,3-dihydro-1H-isoindol-2-yl)-N-methoxy-N-methylacetamide, 95.0%, 10g

1-(Piperidin-4-yl)pyrrolidin-3-ol dihydrochloride, 95+%, 10g

N-(2-METHOXY-4-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)PHENYL)BUTYRAMIDE, 95%, 1g